126 related articles for article (PubMed ID: 37083578)
1. Slowly Expanding 18 F-FDG PET-Positive Irregular Opacities in the Lung Due to Diffuse Lymphoid Hyperplasia Preceding Rheumatoid Arthritis.
Sumitomo K; Okamoto T; Arii K; Matumoto M; Shinohara T
Clin Nucl Med; 2023 Jun; 48(6):542-544. PubMed ID: 37083578
[TBL] [Abstract][Full Text] [Related]
2. Multifocal nodular lymphoid hyperplasia of the lung differently identified by 18F-fluorodeoxyglucose positron emission tomography (FDG-PET).
Nakamura H; Miwa K; Haruki T; Adachi Y; Fujioka S; Taniguchi Y
Thorac Cardiovasc Surg; 2009 Oct; 57(7):439-40. PubMed ID: 19795338
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET scanning in pulmonary amyloidosis.
Baqir M; Lowe V; Yi ES; Ryu JH
J Nucl Med; 2014 Apr; 55(4):565-8. PubMed ID: 24556593
[TBL] [Abstract][Full Text] [Related]
5. IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases.
Kitada M; Matuda Y; Hayashi S; Ishibashi K; Oikawa K; Miyokawa N; Ohsaki Y
J Cardiothorac Surg; 2013 Jun; 8():160. PubMed ID: 23800259
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer.
Bakheet SM; Powe J
J Nucl Med; 1998 Feb; 39(2):234-6. PubMed ID: 9476924
[TBL] [Abstract][Full Text] [Related]
7. Nodular lymphoid hyperplasia: rare case of lymphoproliferative disease in the lung.
Karube Y; Chida M; Honma K; Araki O; Kobayashi S; Miyoshi S
Gen Thorac Cardiovasc Surg; 2009 Jun; 57(6):324-7. PubMed ID: 19533282
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
Kuramoto R; Hirata K; Takei T; Oridate N; Suzuki S; Yamada Y; Imamura M; Tamaki N
Clin Nucl Med; 2011 Jul; 36(7):582-3. PubMed ID: 21637066
[TBL] [Abstract][Full Text] [Related]
9. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
Takanashi S; Nakazato T; Aisa Y; Ito C; Arakaki H; Osada Y; Hirano M; Mori T
Ann Hematol; 2018 Sep; 97(9):1611-1618. PubMed ID: 29713747
[TBL] [Abstract][Full Text] [Related]
12. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
13. [FDG-PET findings of nodular pulmonary amyloidosis with a long-term observation].
Umeda Y; Demura Y; Takeda N; Morikawa M; Uesaka D; Nakanishi M; Mizuno S; Ameshima S; Sasaki M; Itoh H; Ishizaki T
Nihon Kokyuki Gakkai Zasshi; 2007 May; 45(5):424-9. PubMed ID: 17554988
[TBL] [Abstract][Full Text] [Related]
14. Imaging manifestations of autoimmune disease-associated lymphoproliferative disorders of the lung.
Lee G; Lee HY; Lee KS; Lee KJ; Cha HS; Han J; Chung MP
Clin Rheumatol; 2013 Oct; 32(10):1459-65. PubMed ID: 23728499
[TBL] [Abstract][Full Text] [Related]
15. Arterial Inflammation Detected With
Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
[TBL] [Abstract][Full Text] [Related]
16. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Kameda T; Nakashima S; Mitamura K; Yamamoto Y; Norikane T; Shimada H; Wakiya R; Kato M; Miyagi T; Sugihara K; Mino R; Mizusaki M; Kadowaki N; Dobashi H
Sci Rep; 2022 Sep; 12(1):15367. PubMed ID: 36100660
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
19. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
[TBL] [Abstract][Full Text] [Related]
20. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
